Comprehensive Eye Exams

Latest News

First patient enrolled in Ocuphire Phase 3 pivotal trial of Nyxol for presbyopia
January 9th 2023
First patient enrolled in Ocuphire Phase 3 pivotal trial of Nyxol for presbyopia

The VEGA-2 pivotal trial is investigating Nyxol alone and Nyxol with adjunctive low-dose pilocarpine therapy for the treatment of presbyopia.

Ocuphire initiates Global License Agreement for Nyxol eye drops across 3 indications
November 8th 2022

Ocuphire initiates Global License Agreement for Nyxol eye drops across 3 indications